Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 26, 2022
Panoramic Health announced the launch of its clinical research division dedicated to advancing kidney care innovation and improving patient outcomes.
read more
Panthera Biopartners has appointed Chris Dodd as Executive VP of Business Development – Oncology and CNS.
read more
Panthera is on track to have a network of sites open across the UK by the end of the year.
read more
Panthera is now undertaking Phase II, III and IV vaccine trials on behalf of its pharma and CRO clients across its growing network of sites in the UK.
read more
Thursday, August 27, 2020
Since launching its first site in Preston in North West England in 2019, Panthera has expanded its network of UK clinical trial sites with a new site in North London.
read more
Paradigm Clinical Research, with three dedicated research sites in California and Colorado, announced it has grown its executive leadership team, bringing on board Travis Milnes as chief financial officer (CFO) and Amy Henderson as head of clinical ...
read more
Paradigm Clinical Research opened a clinical research site in Littleton, Colorado, their fourth location. The new site location complements the company's long-standing site in Wheat Ridge, Colorado.
read more
Tuesday, November 27, 2012
PAREXEL International Corporation, a leading global biopharmaceutical services provider, and the National Taiwan University Hospital (NTUH) announced today that they have established an alliance. Under the agreement, PAREXEL and NTUH will collaborate...
read more
PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced the appointment of Peter Steiger, Ph.D., to the newly created position of Vice President and Chief Scientific Officer for Medical Imaging....
read more
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the expansion of its global Clinical Logistics Services (CLS) capabilities. A new, state-of-the-art distribution center in ...
read more
PAREXEL International Corporation (Nasdaq: PRXL)(“PAREXEL” or the “Company”), a global clinical research organization, announced today that the Company has acquired all of the outstanding equity securities of ATLAS Medical Services (“ATLAS”), a ...
read more
Thursday, December 27, 2012
PAREXEL International Corporation announced today that on December 21, 2012, the Company acquired all of the outstanding equity securities of Liquent, Inc., a leading global provider of Regulatory Information Management (RIM) solutions. Liquent ...
read more
Tuesday, February 18, 2014
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Perceptive Informatics, the PAREXEL subsidiary that provides the Perceptive MyTrials® eClinical platform and other advanced ...
read more
Wednesday, April 10, 2013
The Society for Clinical Research Sites (SCRS) is pleased to announce that President Christine Pierre has been nominated for the Clinical Trial Business Woman of the Year Award. This prestigious award, granted by the Partnerships in Clinical Trials (...
read more
Tuesday, September 23, 2014
PCI is pleased to announce it has acquired Biotec Services International (Biotec). Biotec is a leading provider of Clinical Trial Services and Temperature Controlled Pharmaceutical Services headquartered in Bridgend, Wales in the United Kingdom. ...
read more